Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APRiCCOT: Antibiotic Combination vs Budesonide in Active Crohn's Disease
NCT01783106Phase 2Completed
- Sponsor
- Royal Liverpool University Hospital
- Start
- Feb 2014
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ciprofloxacin, doxycycline, hydroxychloroquine in Crohn's disease, sponsored by Royal Liverpool University Hospital. Started Feb 2014; status: completed.
02
Drugs
ciprofloxacindoxycyclinehydroxychloroquine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01783106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01783106.